Key facts
| Price (PPV) | 9,355 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | gefitinib |
| Class | Antineoplastic agents |
| ATC code | L01EB01 |
| Manufacturer | AMANYS PHARMA (Ex SAHAM PHARMA) |
| Presentation | Boite de 30 |
| Hospital price | 9,180 MAD |
| Data collected on | 9/8/2026 |
Indications
GEFITINIB 250 mg, comprimé pelliculé est indiqué en monothérapie chez les adultes dans le traitement du cancer bronchique non à petites cellules (CBNPC) localement avancé ou métastatique avec mutations activatrices de l’EGFR-TK.
Find an open pharmacy
On-call pharmacies near you
About Geftinat 250 mg
Geftinat 250 mg belongs to the antineoplastic agents therapeutic class. In Morocco, this drug is marketed by AMANYS PHARMA (Ex SAHAM PHARMA) and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Geftinat 250 mg, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Geftinat 250 mg
Answers to common questions from Moroccan patients about this drug.